Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (431-440 of 974) with videos related to

Pageof 98
Sort By:
The Oncologist|April 5, 2021
Immune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response RatesDmitrii Shek, Scott A Read, Adnan Nagrial, et al.
Annals of the New York Academy of Sciences|June 20, 2020
E-cigarettes damage the liver and alter nutrient metabolism in pregnant mice and their offspringGerard Li, Yik L Chan, Baoming Wang, et al.
Cardiovascular Research|May 26, 2004
Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein IJacob George, Niva Yacov, Eyal Breitbart, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 16, 2025
Clonal hematopoiesis of indeterminate potential: a unifying mechanism linking metainflammation and cardiometabolic diseasesNethma Savindi Wimalarathne, Nick S R Lan, Jacob George, et al.
World Journal of Gastroenterology|August 1, 2013
Resistin mediates the hepatic stellate cell phenotypeZhi-Xia Dong, Lin Su, Joanne Brymora, et al.
American Journal of Physical Medicine & Rehabilitation|December 11, 2013
A rare presentation of subacute progressive ascending myelopathy secondary to cement leakage in percutaneous vertebroplastyRohit Prakash Bhide, Apurba Barman, Shiela Mary Varghese, et al.
Hepatology (Baltimore, Md.)|March 14, 2014
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and CKonstantin Kazankov, Francisco Barrera, Holger Jon Møller, et al.
Cytokine|August 25, 2018
The role of IFN in the development of NAFLD and NASHMichelle Møhlenberg, Ewa Terczynska-Dyla, Karen Louise Thomsen, et al.
Life Science Alliance|August 30, 2023
Polo-like kinase-1 mediates hepatitis C virus-induced cell migration, a drug target for liver cancerKorri E El-Khobar, Enoch Tay, Eve Diefenbach, et al.
The American Journal of Gastroenterology|May 11, 2002
Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistanceJason M Hui, Jacob George, Christopher Liddle, et al.
Pageof 98

Showing results (431-440 of 974) with videos related to

Sort By:
Pageof 98
The Oncologist|April 5, 2021
Immune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response RatesDmitrii Shek, Scott A Read, Adnan Nagrial, et al.
Annals of the New York Academy of Sciences|June 20, 2020
E-cigarettes damage the liver and alter nutrient metabolism in pregnant mice and their offspringGerard Li, Yik L Chan, Baoming Wang, et al.
Cardiovascular Research|May 26, 2004
Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein IJacob George, Niva Yacov, Eyal Breitbart, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 16, 2025
Clonal hematopoiesis of indeterminate potential: a unifying mechanism linking metainflammation and cardiometabolic diseasesNethma Savindi Wimalarathne, Nick S R Lan, Jacob George, et al.
World Journal of Gastroenterology|August 1, 2013
Resistin mediates the hepatic stellate cell phenotypeZhi-Xia Dong, Lin Su, Joanne Brymora, et al.
American Journal of Physical Medicine & Rehabilitation|December 11, 2013
A rare presentation of subacute progressive ascending myelopathy secondary to cement leakage in percutaneous vertebroplastyRohit Prakash Bhide, Apurba Barman, Shiela Mary Varghese, et al.
Hepatology (Baltimore, Md.)|March 14, 2014
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and CKonstantin Kazankov, Francisco Barrera, Holger Jon Møller, et al.
Cytokine|August 25, 2018
The role of IFN in the development of NAFLD and NASHMichelle Møhlenberg, Ewa Terczynska-Dyla, Karen Louise Thomsen, et al.
Life Science Alliance|August 30, 2023
Polo-like kinase-1 mediates hepatitis C virus-induced cell migration, a drug target for liver cancerKorri E El-Khobar, Enoch Tay, Eve Diefenbach, et al.
The American Journal of Gastroenterology|May 11, 2002
Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistanceJason M Hui, Jacob George, Christopher Liddle, et al.
Pageof 98